Equine Medirecord To Be Utilised At 2023 Saudi Cup Meeting

Equine MediRecord will be deployed by the Jockey Club of Saudi Arabia for the two-day $35.35-million Saudi Cup Festival on Feb. 24-25. The meeting features the $20-million G1 Saudi Cup, the world's richest horse race.

The Equine MediRecord platform allows for the full veterinary history of the horse to be recorded securely, ensuring the best possible horse welfare as well as aiding with crucial anti-doping procedures. This platform will provide all entrants, trainers and vets, a system to comply with the latest anti-doping and animal welfare measures. Integrity of this information will be ensured using the Equine MediRecord system and its algorithms which will guarantee the compliance for all horses who participate before they race, ensuring the best possible equine welfare.

Tom Ryan of the Saudi Cup said, “We are delighted to be expanding our Equine MediRecord involvement this year to include an Arabic module. The initial use of the system for the 2022 event was an outstanding success, the core fundamentals of the technology are rock solid.”

Pierce Dargan, Chief Executive Officer of Equine MediRecord, said, “We are thrilled about our partnership with the Jockey Club of Saudi Arabia and doing all we can to help again ensure that the best horse welfare and transparency protocols are followed for this year's Saudi Cup. We are excited to deploy the Arabic version of our Equine MediRecord system with Jockey Club of Saudi Arabia's support and hope this will drive adoption of our system by more equine events in the region who want to ensure the best equine welfare and bio-security protocols are being followed at their events.”

The post Equine Medirecord To Be Utilised At 2023 Saudi Cup Meeting appeared first on TDN | Thoroughbred Daily News | Horse Racing News, Results and Video | Thoroughbred Breeding and Auctions.

Source of original post

No More Needles? New Delivery Methods For Equine Medications On The Horizon

Interest in novel medication administration methods is on the rise as companion animal owners seek less-painful, longer-acting solutions to medication administration. Horse owners, too, are beginning to look for other ways to medicate their mounts that don't rely on the use of needles. 

Equine skin, tendons, and the gastrointestinal tract share many similarities to those of humans, so drugs designed to address issues in humans may often work on horses. However, the relationship isn't always reciprocal: once human dosages are determined, the equine equivalent isn't necessarily considered, but can often be determined, said Dr. Yunmei Song of the Centre for Pharmaceutical Innovation at the University of South Australia.

While human and companion animal medicine have become more focused on ease of administration, Song is hopeful that new drug delivery options are also on the horizon for equine medications. She hopes that these methods will make the medications last longer, easing administration and improving owner compliance – all resulting in improved equine welfare. 

Song did caution that the new treatments will most likely cost more than traditional methods of drug delivery. 

Horses are not often used in pre-clinical testing of drugs, so there is a lack of data on therapeutic molecules and the treatment of different equine diseases. There is limited understanding of how equine anatomy and physiology may affect therapeutically active molecules.

Though oral drug administration is preferred by many horse owners, there are drugs that are absorbed poorly by horses when delivered orally, but are absorbed well in other species. These include tramadol, acyclovir, and furosemide. 

Additionally, how much food is in the horse's stomach can affect how orally-administered medications are absorbed. Because of this, drugs intended to be administered to horses just once a day often will not work well. 

Topical medications used in horses may also have efficacy issues as delivery is highly dependent on the individual horse and his environment.

Even with these possible barriers, there is opportunity for new drug delivery systems to be developed that would require minimal dosing and be easy to administer. One to note is needleless injections, which are gaining traction in human medicine, but present challenges in horses because of skin thickness variability. 

One new medication delivery method that has worked well is the equine inhaler, which is well tolerated by horses and reduces the severity of equine asthma. The research team expects additional medication delivery technology to be created in the future. 

Read more at HorseTalk. 

The post No More Needles? New Delivery Methods For Equine Medications On The Horizon appeared first on Horse Racing News | Paulick Report.

Source of original post

Making Money Using Exacta and Trifecta Plays in Withers Stakes

We’ve reached the halfway point along Aqueduct’s Road to the Kentucky Derby Presented by Woodford Reserve. The third of five Kentucky Derby qualifiers held annually at the New York racetrack is the $250,000, Grade 3 Withers Stakes, slated to take place this Saturday over a distance of 1 1/8 miles on dirt.

Read More...

Source of original post

Verified by MonsterInsights